Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shugan Wan is a traditional Chinese medicine (TCM) product manufactured by Liaoning Jindan Pharmaceutical. It is formulated to soothe the liver, regulate qi, and harmonize the stomach. The preparation typically consists of a complex mixture of herbal ingredients, including *Fructus Toosendan*, *Rhizoma Corydalis*, *Radix Paeoniae Alba*, and *Cortex Magnoliae Officinalis*, among others. It is primarily indicated for the treatment of liver-stomach disharmony, which manifests as distension and pain in the chest and hypochondria, epigastric pain, acid regurgitation, and vomiting. As a multi-component TCM, its therapeutic effect is derived from the synergistic action of various phytochemicals on the digestive and hepatobiliary systems. The product is an approved marketed TCM in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shugan wan.